Medivir Competitors and Similar CompaniesClear all
Medivir's competitors and similar companies include Joint Academy, Anavex, Tetherex and Mirati Therapeutics.
 Medivir Medivir is a company that researches, develops, and sells pharmaceuticals primarily for the treatment of oncology. |  Joint Academy Joint Academy (also known as Arthro Therapeutics) is a digital clinic for patients with osteoarthritis. |  Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases. |  Tetherex Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases. |  Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. | |
Founding Date | Founding Date 1988 | Founding Date 2014 | Founding Date 2006 | Founding Date 2014 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Huddinge, SE HQ | Locations Malmö, SE HQ New York, US | Locations New York, US HQ Reno, US | Locations Oklahoma City, US HQ Morrisville, US | Locations San Diego, US HQ Zug, CH |
Employees | Employees 9 | Employees 983% decrease | Employees 1623% increase | Employees N/A | Employees 666% decrease |
Valuation ($) | Valuation ($) 39.2 m | Valuation ($) N/A | Valuation ($) 484.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) kr8.5m (FY, 2025) | Revenue (est.) kr62.4m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $12.4m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods kr39.8m (FY, 2020) | Cost of goods N/A | Cost of goods N/A | Cost of goods $600k (FY, 2022) |
Gross profit | Gross profit kr8.5m (FY, 2025) | Gross profit kr22.6m (FY, 2020) | Gross profit N/A | Gross profit N/A | Gross profit $11.8m (FY, 2022) |
Net income | Net income (kr94.4m) (FY, 2025) | Net income (kr33.8m) (FY, 2020) | Net income ($46.4m) (FY, 2025) | Net income N/A | Net income ($740.9m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 33.2m | Total funding raised $ 12.6m | Total funding raised $ 46.2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Joint Academy
HQ
Malmö, SE
Joint Academy (also known as Arthro Therapeutics) is a digital clinic for patients with osteoarthritis.
View companyAnavex
HQ
New York, US
Employees
16↑ 23% increase
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
View companyTetherex
HQ
Oklahoma City, US
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
View companyMirati Therapeutics
HQ
San Diego, US
Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
View company